Quest End Period Cash Flow from 2010 to 2024

DGX Stock  USD 163.59  0.30  0.18%   
Quest Diagnostics End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. During the period from 2010 to 2024, Quest Diagnostics End Period Cash Flow regression line of annual values had r-squared of  0.41 and arithmetic mean of  439,250,667. View All Fundamentals
 
End Period Cash Flow  
First Reported
1996-09-30
Previous Quarter
271 M
Current Value
764 M
Quarterly Volatility
301.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.1 M, Interest Expense of 99.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0214 or PTB Ratio of 3.0. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Quest Diagnostics Incorporated over the last few years. It is Quest Diagnostics' End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Quest End Period Cash Flow Regression Statistics

Arithmetic Mean439,250,667
Geometric Mean296,690,436
Coefficient Of Variation87.93
Mean Deviation324,272,889
Median295,600,000
Standard Deviation386,234,281
Sample Variance149176.9T
Range1.2B
R-Value0.64
Mean Square Error94615.4T
R-Squared0.41
Significance0.01
Slope55,371,357
Total Sum of Squares2088476.9T

Quest End Period Cash Flow History

2024720.3 M
2023686 M
2022315 M
2021872 M
20201.2 B
20191.2 B
2018135 M

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow686 M720.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.